On march 6th and 7th Umeå had a prominent visitor from Silicon Valley – the internationally acclaimed pitch coach Nathan Gold. One day was set aside for an exclusive pitch-workshop with startups – the other was a meta-session where the coaches got a brush-up of their own coaching skills – a rather unusual service.
The 14 and 15th of February, Umeå Biotech Incubator organised an Early Drug Development course open to both in-house projects and academics. 20 participants attended, 100 percent would recommend the course, and 90 percent evaluated the content as “very informative”.
Despite the name, the Biotech Umeå Investment Day is not only about raising money and not only strict biotech anymore. This year’s event had a fair representation of innovations from ICT, digital health and chemical. And it seems that the investors are also widening their scope and contributing with more value than just capital to upcoming startups.
The eight consecutive Biotech Umeå Investment Day attracted almost 30 Swedish and international investors to Blasierummet at Grand Hotel on the 2 of February 2017 in Stockholm. One of the most appreciated aspects of the event was the flexibility to arrange additional ad-hoc partnering meetings and the size and atmosphere at the event.
The business coaches at Umeå Biotech Incubator have collected an impressive know-how over the years. With their inside position of some of the most innovative medical solusions they know how to get a life science company to thrive and grow.
Uman Diagnostics, a scientific spin-off company from Umeå University, has recently had it’s technology featured in international top media outlets. New partners in US has put the spotlight on their innovative and quick brain trauma detection technology.
Since 2012 the number of women entrepreneurs in our incubator has tripled. Our CEO, Jennie Ekbeck, attributes the increase to visible role models, national incentives and a strategic long-term approach to include and motivate everyone who is willing to test their idea.
QureTech Bio AB, a start-up at Umeå Biotech Incubator, developing first line drugs to combat antibiotic resistance and infectious diseases, won the BIO-Europe Spring Start-up Slam, in competition with 16 other presentations from 16 other Swedish life sciences start-up companies.